Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Yogen Saunthararajah, MD
Researcher Professor of Medicine
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
Yogen Saunthararajah, MD, is a staff in the department of Hematologic Oncology and Blood Disorders at Cleveland Clinic, a professor of medicine, and co-leader of the developmental therapeutics program of the Case Comprehensive Cancer Center.
His clinical and research interests include acute myeloid leukemia, myelodysplastic syndrome, sickle cell disease/anemia, thalassemia, leukemia, benign hematology, myelodysplasia, cancer, leukopenia, aplastic anemia.
Dr. Yogen developed an Epigenetic Platform that has the potential to identify and eliminate the “road blocks” that prevent cancer cells from becoming specialized, non-dividing cells. According to him, the methodology can be applied to some of the most common and most debilitating genetic disorders in the world, including sickle cell disease and beta thalassemia.
+myBinderRelated Content
-
A systematic review of the literature for severity predictors in pediatric sickle cell anemia patientsBackground: All patients with HbSS (SCA)...
-
Andrew L. (Larry) Frelinger, PhDDr. Frelinger is Assistant Professor of ...
-
Edith Peterson Mitchell, MDEdith Peterson Mitchell, MD, is board ce...
-
Children’s Hospital Oakland Research InstituteDuring our first 50 years, Children’s ...
-
3 Tips about Sickle Cell Disease – Every emergency provider needs to knowChildren and adults with sickle cell dis...
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
-
Sickle Cell Disease Association of America, Inc.SCDAA provides leadership on a national ...
